Sensor-augmented pump therapy at 36 months

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Sensor-augmented pump therapy at 36 months. / Schmidt, Signe; Nørgaard, Kirsten.

In: Diabetes Technology & Therapeutics, Vol. 14, No. 12, 2012, p. 1174-7.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Schmidt, S & Nørgaard, K 2012, 'Sensor-augmented pump therapy at 36 months', Diabetes Technology & Therapeutics, vol. 14, no. 12, pp. 1174-7. https://doi.org/10.1089/dia.2012.0148

APA

Schmidt, S., & Nørgaard, K. (2012). Sensor-augmented pump therapy at 36 months. Diabetes Technology & Therapeutics, 14(12), 1174-7. https://doi.org/10.1089/dia.2012.0148

Vancouver

Schmidt S, Nørgaard K. Sensor-augmented pump therapy at 36 months. Diabetes Technology & Therapeutics. 2012;14(12):1174-7. https://doi.org/10.1089/dia.2012.0148

Author

Schmidt, Signe ; Nørgaard, Kirsten. / Sensor-augmented pump therapy at 36 months. In: Diabetes Technology & Therapeutics. 2012 ; Vol. 14, No. 12. pp. 1174-7.

Bibtex

@article{eed0e402d4204465ab50fa9f99a4d81b,
title = "Sensor-augmented pump therapy at 36 months",
abstract = "This follow-up study investigates the metabolic and psychosocial effects of sensor-augmented pump (SAP) therapy in adults with type 1 diabetes 36 months after therapy start.",
author = "Signe Schmidt and Kirsten N{\o}rgaard",
year = "2012",
doi = "10.1089/dia.2012.0148",
language = "English",
volume = "14",
pages = "1174--7",
journal = "Diabetes Technology & Therapeutics",
issn = "1520-9156",
publisher = "Mary AnnLiebert, Inc. Publishers",
number = "12",

}

RIS

TY - JOUR

T1 - Sensor-augmented pump therapy at 36 months

AU - Schmidt, Signe

AU - Nørgaard, Kirsten

PY - 2012

Y1 - 2012

N2 - This follow-up study investigates the metabolic and psychosocial effects of sensor-augmented pump (SAP) therapy in adults with type 1 diabetes 36 months after therapy start.

AB - This follow-up study investigates the metabolic and psychosocial effects of sensor-augmented pump (SAP) therapy in adults with type 1 diabetes 36 months after therapy start.

U2 - 10.1089/dia.2012.0148

DO - 10.1089/dia.2012.0148

M3 - Journal article

C2 - 23016516

VL - 14

SP - 1174

EP - 1177

JO - Diabetes Technology & Therapeutics

JF - Diabetes Technology & Therapeutics

SN - 1520-9156

IS - 12

ER -

ID: 48544953